Delta-Fly PharmaTSE:4598 +2.27%30 Market Cap is 円1,920.35 Mil as of Jul. 09, 2026. GuruFocus rates TSE:4598 with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 1,421 Biotechnology companies, Delta-Fly Pharma ranks worse than 82.9% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Delta-Fly Pharma's share price for the quarter that ended in Mar. 2026 was 円195. Delta-Fly Pharma's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 13.18 Mil. Therefore, Delta-Fly Pharma's market cap for the quarter that ended in Mar. 2026 was 円2,569.13 Mil.
Delta-Fly Pharma's quarterly market cap
increased
from Mar. 2025 (円5,594.75 Mil) to Sep. 2025 (円6,177.40 Mil) but then
declined
from Sep. 2025 (円6,177.40 Mil) to Mar. 2026 (円2,569.13 Mil).
Delta-Fly Pharma's annual market cap
declined
from Mar. 2024 (円6,888.51 Mil) to Mar. 2025 (円5,594.75 Mil) and
declined
from Mar. 2025 (円5,594.75 Mil) to Mar. 2026 (円2,569.13 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Delta-Fly Pharma's Enterprise Value for Today is 円1,774.90 Mil.
Delta-Fly Pharma (TSE:4598) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Delta-Fly Pharma Market Cap Related Terms
Delta-Fly Pharma Market Cap Historical Data
* Premium members only.
The historical data trend for Delta-Fly Pharma's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4598 vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Delta-Fly Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Delta-Fly Pharma Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Delta-Fly Pharma's Market Cap distribution charts can be found below:
* The bar in red indicates where Delta-Fly Pharma's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Delta-Fly Pharma's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Delta-Fly Pharma (TSE:4598) has a Market Cap of 円1,920.35 Mil as of Jul. 09, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Delta-Fly Pharma and its competitors. According to the industry distribution chart, Delta-Fly Pharma ranks #1178 out of 1421 companies in the Biotechnology industry, placing it in the top 82.9%.
Is Delta-Fly Pharma's Market Cap too high?
Delta-Fly Pharma's current Market Cap is 円1,920.35 Mil. Based on the distribution chart, Delta-Fly Pharma ranks #1178 out of 1421 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Delta-Fly Pharma has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Delta-Fly Pharma's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Delta-Fly Pharma ranks #1178 out of 1421 companies for Market Cap. This places Delta-Fly Pharma in the lower half of its industry. The industry median Market Cap is 119.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.86, based on 1,421 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Delta-Fly Pharma and its competitors. For the Biotechnology industry, the median Market Cap is 119.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Delta-Fly Pharma's current Market Cap is 円1,920.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delta-Fly Pharma stock overvalued right now?
Delta-Fly Pharma (TSE:4598) has a current Market Cap of 円1,920.35 Mil. The current Market Cap is 円1,920.35 Mil. Delta-Fly Pharma's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Delta-Fly Pharma (TSE:4598), the current Market Cap is 円1,920.35 Mil as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4598 has been successfully added to your 
